Cetuximab EGFR inhibitors

Erbitux - C225 - MAb C225 - IMC-C225 - IMC C225



Trial Studied treatment Control Patients Size Study type Results NCT

Lung cancer (metastatic) - EGFR inhibitors in all type of patients

Lynch, 2010cetuximabCTNA
Butts, 2007cetuximabCT alone131 (65/66)
FLEX (Pirker), 2009cetuximab + CTCT alone1125 (557/568) NCT00148798
Rosell, 2008cetuximab + CTCT alone86 (43/43)



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons